LAPIX Therapeutics Inc.
4 clinical trials · Sponsor
◉ Watch LAPIX Therapeutics Inc.
| Record | Firm | Date |
|---|---|---|
| Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis (NCT06982352) | LAPIX Therapeutics Inc. | 2025-06-15 |
| Safety and Pharmacokinetics of LPX-TI641 in Rheumatoid Arthritis and Psoriatic Arthritis (NCT06628206) | LAPIX Therapeutics Inc. | 2024-12-15 |
| First-in-Human Trial in Healthy Adult Volunteers to Evaluate Safety, Tolerability and PK of LAPIX Study Drug; LPX-TI641 (NCT05853835) | LAPIX Therapeutics Inc. | 2023-10-30 |
| An Observational Biomarker Study in Multiple Sclerosis (MS) Patients (NCT05663853) | LAPIX Therapeutics Inc. | 2023-03-28 |
Track LAPIX Therapeutics Inc. automatically
Every clearance here is in the API, with alerts when new ones post.